Renaissance Technologies - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$4,541
-26.8%
1,726,602
-1.8%
0.01%
-11.1%
Q2 2023$6,206
+9.5%
1,758,013
-4.2%
0.01%
+12.5%
Q1 2023$5,670
-21.1%
1,834,913
+8.0%
0.01%
-20.0%
Q4 2022$7,186
-99.8%
1,698,843
-5.6%
0.01%
+66.7%
Q3 2022$4,265,000
-24.3%
1,799,662
-9.0%
0.01%
-14.3%
Q2 2022$5,634,000
+10.4%
1,976,935
+11.6%
0.01%
+16.7%
Q1 2022$5,101,000
-7.8%
1,771,235
-2.7%
0.01%
-14.3%
Q4 2021$5,535,000
-51.6%
1,820,858
+11.6%
0.01%
-53.3%
Q3 2021$11,440,000
-22.0%
1,631,935
+2.1%
0.02%
-16.7%
Q2 2021$14,673,000
-5.2%
1,598,335
+0.4%
0.02%
-5.3%
Q1 2021$15,477,000
-9.2%
1,592,235
-4.2%
0.02%0.0%
Q4 2020$17,046,000
+8.9%
1,661,435
+7.1%
0.02%
+18.8%
Q3 2020$15,657,000
+2.4%
1,551,697
+5.9%
0.02%
+23.1%
Q2 2020$15,287,000
+66.4%
1,465,697
+34.6%
0.01%
+44.4%
Q1 2020$9,188,000
+977.1%
1,088,597
+1016.5%
0.01%
+800.0%
Q4 2019$853,000
-73.4%
97,500
-61.3%
0.00%
-66.7%
Q2 2019$3,205,000
-10.1%
252,200
+174.4%
0.00%0.0%
Q1 2019$3,565,000
-36.9%
91,900
-66.9%
0.00%
-50.0%
Q4 2018$5,649,000
-65.0%
277,600
+106.2%
0.01%
-68.4%
Q3 2017$16,118,000
+109.8%
134,600
-34.8%
0.02%
+72.7%
Q1 2017$7,682,000
-37.3%
206,500
+27.0%
0.01%
-62.1%
Q3 2015$12,254,000
+70.1%
162,600
+438.4%
0.03%
+45.0%
Q3 2014$7,205,000
+449.2%
30,200
+139.7%
0.02%
+566.7%
Q1 2014$1,312,00012,6000.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,536,156$21,405,0002.24%
Palo Alto Investors LP 1,396,163$11,784,0000.99%
Camber Capital Management LP 1,950,000$16,458,0000.98%
TANG CAPITAL MANAGEMENT LLC 800,000$6,752,0000.95%
Capital Impact Advisors, LLC 147,303$1,243,0000.52%
Sofinnova Investments, Inc. 638,026$5,385,0000.50%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 963,212$8,130,0000.26%
RICE HALL JAMES & ASSOCIATES, LLC 466,482$3,937,0000.22%
PDT Partners, LLC 204,238$1,724,0000.14%
Eversept Partners, LP 58,251$491,6380.12%
View complete list of PUMA BIOTECHNOLOGY INC shareholders